On the Front Lines of Heart Failure: Best Practices and Evolving Evidence in Cardiorenal Care for the Multidisciplinary Team - CME - Guideline Central

CME

Title
On the Front Lines of Heart Failure: Best Practices and Evolving Evidence in Cardiorenal Care for the Multidisciplinary Team
Link
Description
Heart failure (HF) is becoming increasingly prevalent and continues to drive significant morbidity and mortality across the full cardiovascular-kidney-metabolic (CKM) continuum, wherein delayed disease recognition, suboptimal treatment selection, and fragmented care patterns each contribute deleterious impacts to the quality and outcomes of cardiorenal care. In fact, the profound epidemiologic scope and burgeoning need for optimized management of CKM has recently prompted the promulgation of the 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of CKM Syndrome, the first-ever expert consensus guidance statement to be published in this rapidly evolving field.
Target Audience
Designed for the multidisciplinary team, this program emphasizes collaborative, evidence-driven, and patient-centered strategies to optimize outcomes in HF.
Learning Objectives
  • Review the prevalence and clinical impact of heart failure (HF), and its connection to the cardiovascular-kidney-metabolic (CKM) disease continuum.
  • Examine the central role of aldosterone in HF pathophysiology and progression—and why it remains a critical therapeutic target.
  • Apply best practice approaches for early identification and diagnosis of HF, ensuring rapid initiation of guideline-directed medical therapy (GDMT).
  • Integrate patient-centered, guideline-based treatment plans through effective multidisciplinary and interprofessional collaboration.
  • Evaluate the latest evidence for existing and novel HF therapeutics that target aldosterone.
Estimated Duration
60 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Endocrinology, Cardiology, Nephrology, Internal Medicine - General, Family Medicine
Keywords
heart failure
Disclosures and Disclaimers
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Accredited Providers
  • American Academy of CME
Commercial Support
  • Boehringer Ingelheim Pharmaceuticals, Inc
Activity Expiration Date
June 1, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1 CreditsACCME- Accreditation Council for Continuing Medical Education
Nursing1 Contact HoursANCC - American Nurses Credentialing Center
AAPA Category 1 Credit1 CreditsAAPA- American Academy of Physician Associates
Pharmacy1 Contact HoursACPE- Accreditation Council for Pharmacy Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.